Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
This article was originally published in The Pink Sheet Daily
Executive Summary
The public-private partnership includes Pfizer, Johnson & Johnson, Abbott, Medtronic, General Electric, Chindex and Microsoft.
You may also be interested in...
Long-term Backer Of Stronger Trade Ties With China, U.S. Senator Warns Of Potential Economic Face-off
BEIJING - With the American economy still reeling from debilitating unemployment levels and a burgeoning international trade deficit, U.S. Senator Max Baucus (D-Mont.) jetted into Beijing this week in an attempt to resolve a series of economic disputes with China; talks with Chinese leaders could trigger changes that affect virtually every sector, including healthcare
Barack Obama's Meeting With Chinese President Bodes Well For Pan-Pacific Pharma Partnerships, Says Analyst During Shanghai Conference
SHANGHAI - Despite the financial maelstrom that has lashed economies from the Americas to Asia, U.S. President Barack Obama's April 1 meeting with Chinese President Hu Jintao is ultimately likely to boost the pharmaceutical sector in each country and the potential for pan-Pacific partnerships, according to the chief executive officer of the San Diego-based consulting firm BioForesight
Import Safety Agreement Further Entwines FDA/China Regulatory Process
Chinese manufacturers of certain drugs or active pharmaceutical ingredients selected by FDA will have to meet new registration standards as part of a memorandum of understanding signed Dec. 11 in Beijing by HHS, FDA and China's State Food and Drug Administration